Cisen Pharmaceutical Co., Ltd. Stock: price and insider trades · China
辰欣药业
No insider purchase over the last 90 days. The latest, by 杜振新, was filed 20 Oct 2022.
Cisen Pharmaceutical Co., Ltd.: what insiders have been doing
Cisen Pharmaceutical Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). No insider at Cisen Pharmaceutical Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 20 October 2022.
The full history, which starts in 2022, counts 3 purchases against no sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- +0.2%Entry CN¥12.57 · Close at T+365 CN¥12.59
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 363,800 shares28.2% of flowA股XSHGSSE:173000005968855230Canonical exit: 18 Jan 2023 (T+90)
- 458,700 shares35.6% of flowA股XSHGSSE:173000005719617150Canonical exit: 24 Oct 2022 (T+90)
- 478,200 shares36.3% of flowA股XSHGSSE:173000005480469250Canonical exit: 26 Jul 2022 (T+90)
3 of 3 declarations
About Cisen Pharmaceutical Co., Ltd.
辰欣药业 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and manufacturing of innovative medicines.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
